Appendix B. Sources of evidence considered by the Committee

Appendix B. Sources of evidence considered by the Committee

The following documentation and opinions were made available to the Committee:

A The Assessment Report for this appraisal was prepared by Liverpool Reviews and Implementation Group, University of Liverpool.

  • Coronary artery stents: rapid systematic review & economic evaluation, February 2003

  • Assessment report – addendum A – data no longer confidential, June 2003

  • Assessment report – addendum B - further analysis requested by the Appraisal Committee, May 2003

B The following organisations accepted the invitation to participate in this appraisal. They were invited to make submissions and comment on the draft scope, Assessment Report and the Appraisal Consultation Document (ACD). Consultee organisations are provided with the opportunity to appeal against the Final Appraisal Determination.

I Manufacturer/sponsors:

  • Abbott Vascular Devices Ltd

  • Bard Ltd

  • Biotronik UK Ltd

  • Boston Scientific Ltd

  • Cordis

  • Guidant Ltd

  • Jomed UK Ltd

  • Kimal

  • Medtronic Ltd

  • Sorin Biomedica UK Ltd

  • Terumo UK

  • WL Gore & Associates

II Professional/specialist and patient/carer groups:

  • Action Heart

  • Association of British Health-Care Industries

  • British Cardiac Industry Association

  • British Cardiovascular Intervention Society

  • British Cardiac Patients Association

  • British Cardiac Society

  • British Cardiovascular Industry Association

  • British Heart Foundation

  • Department of Health

  • EUCOMED

  • Heart UK

  • National Collaborating Centre for Chronic Conditions

  • NHS Quality Improvement Scotland

  • Royal College of Nursing

  • Royal College of Physicians

  • Southwark PCT & South East Public Health Network

  • Welsh Assembly Government

C The following individuals were selected from clinical expert and patient advocate nominations from the professional/specialist and patient/carer groups. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on coronary artery stents by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Dr Mark de Belder, Assistant Secretary, British Cardiac Society & Consultant Cardiologist, The James Cook University Hospital, Middlesbrough

  • Dr Derek Connolly, Consultant Cardiologist, Heart UK & Sandwell and West Birmingham Hospitals NHS Trust AND Honorary Clinical Senior Lecturer, University of Birmingham

  • Dr A H Gershlick, Consultant Cardiologist, Department of Cardiology, Glenfield Hospital NHS Trust, Leicester

  • Mr S Livesey, Consultant Cardiac Surgeon, Southampton General Hospital

  • Professor M Rothman, Consultant Cardiologist, London Chest Hospital